Combined oral contraceptive use and serotonin 2A and 2C receptor brain architecture in healthy women
View ORCID ProfileAnna Kauffmann, Anjali Sankar, Vincent Beliveau, Claus Svarer, Brice Ozenne, Patrick MacDonald Fisher, Vibe G. Frokjaer, View ORCID ProfileSøren Vinther Larsen
doi: https://doi.org/10.1101/2025.07.08.25331039
Anna Kauffmann
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
Anjali Sankar
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
Vincent Beliveau
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
bInstitute for Human Genetics, Medical University of Innsbruck, Innsbruck, Austria
Claus Svarer
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
Brice Ozenne
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
cDepartment of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark
Patrick MacDonald Fisher
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
dDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark
Vibe G. Frokjaer
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
eDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
fPsychiatric Center Copenhagen, Mental Health Services in the Capital Region of Denmark, Copenhagen, Denmark
Søren Vinther Larsen
aNeurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark
eDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted July 10, 2025.
Combined oral contraceptive use and serotonin 2A and 2C receptor brain architecture in healthy women
Anna Kauffmann, Anjali Sankar, Vincent Beliveau, Claus Svarer, Brice Ozenne, Patrick MacDonald Fisher, Vibe G. Frokjaer, Søren Vinther Larsen
medRxiv 2025.07.08.25331039; doi: https://doi.org/10.1101/2025.07.08.25331039
Combined oral contraceptive use and serotonin 2A and 2C receptor brain architecture in healthy women
Anna Kauffmann, Anjali Sankar, Vincent Beliveau, Claus Svarer, Brice Ozenne, Patrick MacDonald Fisher, Vibe G. Frokjaer, Søren Vinther Larsen
medRxiv 2025.07.08.25331039; doi: https://doi.org/10.1101/2025.07.08.25331039
Subject Area
Subject Areas
- Addiction Medicine (576)
- Allergy and Immunology (868)
- Anesthesia (306)
- Cardiovascular Medicine (4483)
- Dermatology (385)
- Emergency Medicine (615)
- Epidemiology (15283)
- Forensic Medicine (31)
- Gastroenterology (1134)
- Genetic and Genomic Medicine (6651)
- Geriatric Medicine (671)
- Health Economics (1006)
- Health Informatics (4606)
- Health Policy (1378)
- Hematology (545)
- HIV/AIDS (1276)
- Medical Education (626)
- Medical Ethics (147)
- Nephrology (675)
- Neurology (6699)
- Nursing (346)
- Nutrition (1006)
- Obstetrics and Gynecology (1153)
- Oncology (3370)
- Ophthalmology (989)
- Orthopedics (370)
- Otolaryngology (421)
- Pain Medicine (437)
- Palliative Medicine (131)
- Pathology (670)
- Pediatrics (1704)
- Primary Care Research (717)
- Public and Global Health (9288)
- Radiology and Imaging (2225)
- Respiratory Medicine (1202)
- Rheumatology (598)
- Sports Medicine (536)
- Surgery (722)
- Toxicology (100)
- Transplantation (290)
- Urology (267)




